Skip to main content

Advertisement

Table 5 Haplotype analysis associated with chemosensitivity in SETD2 polymorphism

From: Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients

Haplotype CR (n, %) NR (n, %) χ2 p OR (95% CI)
AGC 188 (50.9%) 102 (56.6%) 2.871 0.090 0.803 (0.623–1.035)
GAC 127 (34.3%) 62 (34.5%) 0.000 0.998 1.000 (0.767–1.303)
GGT 51 (13.9%) 16 (8.4%) 6.679 0.010 1.738 (1.138–2.652)